Hot and Cold Therapy Packs Market Will Grow Fastest in Asia-Pacific

The total revenue generated by the hot and cold therapy packs market will grow at a rate of 7.7% in the years to come to reach USD 2,008.2 million by 2030.

To learn more about this report: https://bit.ly/3IWbdy6

The factors responsible for the market growth are increasing acceptance of non-pharma and non-invasive pain management therapies, increasing elderly population, increasing incidence of orthopedic ailments, growing product introductions, and the increasing count of road accidents.

Cold therapy packs dominated the industry in the past, and the situation will remain like this in the years to come. This is because these packs are highly favored by individuals, who are suffering with chronic joint and bone pain.

APAC will grow the fastest in the years to come, mostly because of the surging elderly population, which generates a high requirement for non-invasive pain management therapies, as stated in one of its market research reports by P&S Intelligence.

As per the WHO, 20–50 million individuals bear non-fatal injuries on a yearly basis, which result in long-standing disabilities. Since people suffering from injuries non the road injuries are generally treated with hot and cold therapy packs for the management of pain, the increasing count of road accidents is ensuing in the increasing requirement for these products, thus boosting the growth of the industry.

There are an increasing cases of road accidents of-late all over the world, and this will help in increasing the demand for hot and cold therapy packs in the future.

Read More

Rising Prevalence of Chronic Health Disorders Drive Chronic Pain Treatment Industry

Over 60% of people in the world will increase from 12% to 22% between 2015 and 2050, as per the WHO. Moreover, a major issue for care facilities is the high prevalence of chronic pain among older residents in nursing homes.

Pharmacological, non-pharmacological (physical therapy, such as exercise, foot orthotics, or patellar taping for knee osteoarthritis) and occupational therapies (assistive devices and joint protection education) are the main treatments used to treat this condition in the elderly population, which in turn has a positive impact on the need for chronic pain treatment.  

The main growth factors for the worldwide chronic pain treatment market are the growing geriatric population, rising elderly population, and rising prevalence of chronic health disorders. The sector will generate USD 162,175.2 million in sales in 2030 as a result of the aforementioned causes, as per P&S Intelligence.

Get the sample pages of this report: https://bit.ly/3LAuXJq

One of the biggest healthcare burdens on the planet, which affects both high-income and low- and middle-income countries, is the increased prevalence of chronic diseases. Moreover, osteoarthritis, fibromyalgia, cancer, sickle-cell anemia, and autoimmune disorders (rheumatoid arthritis) are a few examples of chronic diseases that call for therapeutic intervention for effective pain management.

Cancer Pain Categories Will See Rapid Growth

According to predictions, the category of cancer pain will rise the fastest in the future. Cancer is one of the top causes of death worldwide, according to the NCI.

By 2040, it is anticipated that there would be 29.5 million new instances of cancer diagnosed annually, with 16.4 million cancer-related deaths. As a result, the market is being driven by the growing number of cancer survivors because the condition results in severe, prolonged pain.

The hospitals category will achieve the highest growth rate in the years to come. Hospitals are the places where pain management procedures are used most frequently, especially for post-surgical pain, where the high cost of monitoring and treating side effects results in the need for pain management treatment and medications.

North America Led Market Demand

Geographically, North America was the highest revenue generator in the chronic pain treatment market in 2020 due to the high healthcare spending, developed healthcare infrastructure, and widespread accessibility to cutting-edge medications and medical equipment.

On the other hand, the APAC market is anticipated to experience the quickest growth during the forecast period, largely due to the region's expanding elderly population, improved healthcare infrastructure, rising per capita income, and surging cases of chronic pain. 

Drugs Categories Dominate Industry

The market for treating chronic pain was dominated by the medication category. This is partly because several chronic pain conditions, such as excruciating headaches or migraine pain, lower back pain, and facial discomfort, are becoming more common. 

Additionally, the market for painkiller medications will grow due to the increasing senior population worldwide, sedentary lifestyle, and increase in surgical operations. 

According to the application, the musculoskeletal category accounted for the largest share of the market for treating chronic pain. The high prevalence of musculoskeletal conditions including fibromyalgia, osteoarthritis, and rheumatoid arthritis is mostly to blame for this.

Read More